Ryanne W Lieshout-Krikke1, Dragoslav Domanovic2, Wim De Kort3, Wolfgang Mayr4, Giancarlo M Liumbruno5, Simonetta Pupella5, Johann Kurz6, Folke Knutson7, Sheila Maclennan8, Gilles Folléa9. 1. Sanquin Blood Supply Foundation, Department of Blood-borne Infections, Amsterdam, the Netherlands. 2. European Centre for Disease Prevention and Control, Department Surveillance and Response Support, Stockholm, Sweden. 3. Sanquin Blood Supply Foundation, Department Donor Studies, Amsterdam, the Netherlands. 4. Austrian Red Cross Blood Transfusion Service, Vienna, Austria. 5. Italian National Blood Centre, National Institute of Health, Rome, Italy. 6. retired from the Federal Ministry of Health, Vienna, Austria. 7. Section of Clinical Immunology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. 8. NHS Blood and Transplant, Department Leeds Centre, Leeds, United Kingdom. 9. French Blood Establishment (EFS), Saint Denis, France.
Abstract
BACKGROUND: Two selection strategies for newly-registered blood donors are available: a single-visit selection called the standard selection procedure (SSP), and a two-stage selection named predonation and donation screening (PDS). This study reviews the selection strategies for newly-registered donors currently applied in European countries. MATERIAL AND METHODS: We collected data on donor selection procedures, blood donation, laboratory screening and HIV, HCV and HBV positive donors/donations from 2010 to 2013 in 30 European countries by using questionnaires. We grouped the countries according to the applied selection strategy, and for each country, we calculated the 4-year prevalence of confirmed positive results indicating the presence of overall and recent HIV, HCV and HBV infections among first-time and repeat donations and among newly-registered donors. RESULTS: Most of the 24 countries (80%) apply the SSP strategy for selection of newly-registered donors. Twenty-two countries (73.3%) employ a nucleic acid amplification testing in addition to the mandatory serological screening. The survey confirms a higher overall prevalence of HIV, HCV and HBV infections among first-time donations and newly-registered donors than among repeat donations. In contrast, the prevalence of recently acquired HIV and HCV infections was lower among first-time donations and newly-registered donors than among repeat donations, but higher for recent HBV infections (6.7/105 vs 2.6/105 in the SSP setting and 4.3/105 vs 0.5/105 in one country using PDS). The relatively low numbers of infected donors selected by PDS impeded accurate assessment of the prevalence of recent infections in first-time donations. DISCUSSION: The data from European countries provide inconclusive evidence that applying PDS reduces the risk of donations being made in the diagnostic window of first-time donors. The impact of PDS on the risk of window-period donations and blood donor management needs further investigation.
BACKGROUND: Two selection strategies for newly-registered blood donors are available: a single-visit selection called the standard selection procedure (SSP), and a two-stage selection named predonation and donation screening (PDS). This study reviews the selection strategies for newly-registered donors currently applied in European countries. MATERIAL AND METHODS: We collected data on donor selection procedures, blood donation, laboratory screening and HIV, HCV and HBV positive donors/donations from 2010 to 2013 in 30 European countries by using questionnaires. We grouped the countries according to the applied selection strategy, and for each country, we calculated the 4-year prevalence of confirmed positive results indicating the presence of overall and recent HIV, HCV and HBV infections among first-time and repeat donations and among newly-registered donors. RESULTS: Most of the 24 countries (80%) apply the SSP strategy for selection of newly-registered donors. Twenty-two countries (73.3%) employ a nucleic acid amplification testing in addition to the mandatory serological screening. The survey confirms a higher overall prevalence of HIV, HCV and HBV infections among first-time donations and newly-registered donors than among repeat donations. In contrast, the prevalence of recently acquired HIV and HCV infections was lower among first-time donations and newly-registered donors than among repeat donations, but higher for recent HBV infections (6.7/105 vs 2.6/105 in the SSP setting and 4.3/105 vs 0.5/105 in one country using PDS). The relatively low numbers of infected donors selected by PDS impeded accurate assessment of the prevalence of recent infections in first-time donations. DISCUSSION: The data from European countries provide inconclusive evidence that applying PDS reduces the risk of donations being made in the diagnostic window of first-time donors. The impact of PDS on the risk of window-period donations and blood donor management needs further investigation.
Authors: P Gillet; A Rapaille; A Benoît; M Ceinos; O Bertrand; I de Bouyalsky; B Govaerts; M Lambermont Journal: Transfus Clin Biol Date: 2015-10-23 Impact factor: 1.406
Authors: Wim de Kort; Peter van den Burg; Herman Geerligs; Pieternel Pasker-de Jong; Tanneke Marijt-van der Kreek Journal: Transfusion Date: 2013-07-25 Impact factor: 3.157
Authors: Ebru K Bish; Prasanna K Ragavan; Douglas R Bish; Anthony D Slonim; Susan L Stramer Journal: Biostatistics Date: 2014-04-30 Impact factor: 5.899
Authors: Michael P Busch; Simone A Glynn; Susan L Stramer; D Michael Strong; Sally Caglioti; David J Wright; Brandee Pappalardo; Steven H Kleinman Journal: Transfusion Date: 2005-02 Impact factor: 3.157
Authors: Susan L Stramer; Simone A Glynn; Steven H Kleinman; D Michael Strong; Sally Caglioti; David J Wright; Roger Y Dodd; Michael P Busch Journal: N Engl J Med Date: 2004-08-19 Impact factor: 91.245
Authors: Giuseppe Marano; Massimo Franchini; Liviana Catalano; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno Journal: Ann Transl Med Date: 2017-12